EPO and anemia (phenotype): A study by Keast et al. on patients with stage 4 pressure ulcers who received human recombinant erythropoietin for 6 weeks to treat anemia of chronic disease found that all patients experienced not only an increase in hemoglobin levels but also an improvement in the condition of their ulcers.